Most lately, it's been recognized that conolidine and the above derivatives act about the atypical chemokine receptor 3 (ACKR3. Expressed in very similar locations as classical opioid receptors, it binds to some big range of endogenous opioids. As opposed to most opioid receptors, this receptor acts for a scavenger and won't activate a second messe